![Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets - PR Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets - PR](https://mma.prnasia.com/media2/1916090/Pierre_Fabre_Gennisium__Logo.jpg?p=medium600)
Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets - PR
![Bormioli Pharma and Pierre Fabre Develop a 100% Recycled PET packaging for ELUDRIL® Brand Mouthwashes - EU Business News Bormioli Pharma and Pierre Fabre Develop a 100% Recycled PET packaging for ELUDRIL® Brand Mouthwashes - EU Business News](https://www.eubusinessnews.com/wp-content/themes/wp-bootstrap-starter/aigm-image-handler/handler.gz?src=https%3A%2F%2Fwww.eubusinessnews.com%2Fwp-content%2Fuploads%2F2022%2F10%2FBormioli-Pharma.jpg&width=654&height=auto&format=webp)
Bormioli Pharma and Pierre Fabre Develop a 100% Recycled PET packaging for ELUDRIL® Brand Mouthwashes - EU Business News
![Dexeryl Creme von PIERRE FABRE DERMO KOSMETIK GmbH GB - DUCRAY A-DERMA PFD Spitzweg-Apotheke Herzogenrath Dexeryl Creme von PIERRE FABRE DERMO KOSMETIK GmbH GB - DUCRAY A-DERMA PFD Spitzweg-Apotheke Herzogenrath](https://cdn1.apopixx.de/1000/web_schraeg/07379385.jpg)